What workup, if any, is indicated for a 66-year-old man with an incidental hematocrit of 39.6%, platelet count of 403 ×10⁹/L, and immature granulocytes of 1.3%?

Workup for Incidental Hematocrit 39.6%, Platelet 403, and Immature Granulocytes 1.30%

This 66-year-old male requires minimal workup focused on confirming the immature granulocyte elevation and excluding infection or early myeloproliferative disorder, but the hematocrit and platelet values are within normal limits and do not require intervention.

Assessment of Individual Parameters

Hematocrit 39.6%

• This hematocrit is completely normal for an adult male (normal range 42-54%), falling well below any threshold requiring evaluation for erythrocytosis. 1
• Erythrocytosis evaluation is only indicated when hemoglobin exceeds 18.5 g/dL or hematocrit exceeds 52% in men. 1
• No further workup is needed for this parameter.

Platelet Count 403 × 10⁹/L

• This platelet count is mildly elevated but below the threshold for essential thrombocythemia (which requires sustained elevation >450 × 10⁹/L). 2
• In the context of a myeloproliferative disorder, uncontrolled myeloproliferation is defined as platelet count >400 × 10⁹/L and WBC >10 × 10⁹/L after 3 months of therapy—this patient has neither confirmed diagnosis nor treatment. 1
• A single mildly elevated platelet count (403) can be reactive and does not automatically warrant extensive workup in an asymptomatic patient.

Immature Granulocytes 1.30%

This is the only abnormal finding requiring attention.

• The upper reference limit for immature granulocytes in adults over age 10 is 0.90%, making this patient's value of 1.30% definitively elevated. 1, 3
• Immature granulocytes above 3% are highly specific for sepsis, but values between 0.90-3% have a broader differential diagnosis. 4
• In outpatients over age 10, the most common causes of elevated immature granulocytes are hematologic malignancies, glucocorticoid or chemotherapy use, severe infections, and (in young females) pregnancy. 3

Recommended Workup

Immediate Clinical Assessment

• Evaluate for fever (temperature >100°F or ≥2 readings >99°F) and focal infection symptoms including respiratory, urinary, gastrointestinal, or skin/soft tissue signs. 5
• Review medication history specifically for glucocorticoids, chemotherapy agents, or any myelosuppressive drugs. 3
• Assess for constitutional symptoms such as weight loss, night sweats, early satiety, or splenomegaly that might suggest a myeloproliferative disorder. 2

Laboratory Evaluation

• Repeat complete blood count with differential in 2-4 weeks to determine if the immature granulocyte elevation is persistent or transient. 1
• Obtain peripheral blood smear review to assess for dysplasia, blasts, or other morphologic abnormalities that might suggest myelodysplasia or leukemia. 1, 6
• If fever or infection signs are present, obtain blood cultures before any antibiotics. 5

When to Pursue Further Testing

• If immature granulocytes remain elevated on repeat testing (>0.90%) without clear infectious or medication cause, consider:
  • JAK2 mutation testing to evaluate for polycythemia vera or other myeloproliferative neoplasms 1
  • Referral to hematology for consideration of bone marrow biopsy if peripheral smear shows dysplasia or if other cytopenias develop 6

Common Pitfalls to Avoid

• Do not pursue extensive erythrocytosis workup for a normal hematocrit of 39.6%—this wastes resources and may lead to unnecessary interventions. 1
• Do not ignore the elevated immature granulocytes simply because the absolute value is modest; persistent elevation warrants investigation for underlying myeloproliferative or infectious processes. 3, 4
• Do not attribute isolated thrombocytosis to essential thrombocythemia without sustained elevation >450 × 10⁹/L and exclusion of reactive causes. 2
• Do not delay bone marrow examination if pancytopenia develops or if peripheral smear shows blasts, as this could represent acute leukemia requiring urgent treatment. 6

Monitoring Strategy

• For asymptomatic patients with isolated mild immature granulocyte elevation, serial CBC monitoring every 4-6 weeks is appropriate to detect progression or resolution. 1
• If values normalize on repeat testing and patient remains asymptomatic, no further workup is needed.
• If immature granulocytes increase or additional cytopenias develop, immediate hematology referral is indicated. 6